The role of multimodality imaging in the selection and management of patients treated with cytoreductive surgery and HIPEC.

Published Date: 08th July 2024

Publication Authors: John. V, Kim. K

Abstract: 

Cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC) is the mainstay of potentially curative surgical treatment for malignancies that have spread to peritoneal surfaces. This surgical procedure is however associated with high morbidity and appropriate patient selection and planning is therefore essential. Available multimodality imaging techniques include CT with oral and intravenous contrast, MRI including use of dedicated peritoneal protocol and FDG-PET/CT. These used with the correct technique, read by specialist radiologists and discussed under the auspices of a dedicated multidisciplinary team, can help to improve outcomes. We demonstrate that imaging not only provides information about peritoneal disease burden but more importantly want to shift the reader's focus to disease distribution. Our examples highlight how imaging helps avoid futile surgery by identifying patients with disease in unfavourable sites and show the strength and limitations of the various imaging modalities. We share how MR imaging can help identify multifocal and often occult sites including widespread miliary disease. Our examples provide a comprehensive overview demonstrating how imaging can help plan surgery by identifying patients who may need splenic vaccinations, counselling for stoma, egg harvesting and input from surgeons with other specialist expertise greatly increasing likelihood of achieving complete cytoreduction.

John, V; Kim, K; Et al. (2024). The role of multimodality imaging in the selection and management of patients treated with cytoreductive surgery and HIPEC. Abdominal Radiology. 49(12), pp.4352 - 4364. [Online]. Available at: 10.1007/s00261-024-04441-2 [Accessed 7 November 2024].

« Back